These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27709364)

  • 1. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.
    Coelho M; Soares-Silva C; Brandão D; Marino F; Cosentino M; Ribeiro L
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):275-291. PubMed ID: 27709364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects of β-blockers on human colorectal cancer cells.
    Coelho M; Moz M; Correia G; Teixeira A; Medeiros R; Ribeiro L
    Oncol Rep; 2015 May; 33(5):2513-20. PubMed ID: 25812650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Adrenoceptors in Cancer: Old Players and New Perspectives.
    Amato R; Lucchesi M; Marracci S; Filippi L; Dal Monte M
    Handb Exp Pharmacol; 2024; 285():665-688. PubMed ID: 37982890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference.
    He RH; He YJ; Tang YJ; Zhou HH; McLeod HL; Liu J
    Pharmacogenomics; 2016; 17(1):74-9. PubMed ID: 26652861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via β-adrenergic receptor-dependent activation of P38/MAPK pathway.
    Huang XY; Wang HC; Yuan Z; Huang J; Zheng Q
    Hepatogastroenterology; 2012 May; 59(115):889-93. PubMed ID: 22020907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers.
    Nilsson MB; Le X; Heymach JV
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):27-36. PubMed ID: 31828732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy.
    Tang J; Li Z; Lu L; Cho CH
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):533-42. PubMed ID: 24012659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic implications of beta-adrenergic receptor pharmacodynamic properties.
    Taira CA; Carranza A; Mayer M; Di Verniero C; Opezzo JA; Höcht C
    Curr Clin Pharmacol; 2008 Sep; 3(3):174-84. PubMed ID: 18781904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
    Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
    Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation.
    Gerhardt CC; Gros J; Strosberg AD; Issad T
    Mol Pharmacol; 1999 Feb; 55(2):255-62. PubMed ID: 9927616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathways: beta-adrenergic signaling in cancer.
    Cole SW; Sood AK
    Clin Cancer Res; 2012 Mar; 18(5):1201-6. PubMed ID: 22186256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of β-adrenergic receptors in the cardioprotective effects of beta-preconditioning (βPC).
    Salie R; Moolman JA; Lochner A
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):31-46. PubMed ID: 21225332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors.
    Cleveland KH; Liang S; Chang A; Huang KM; Chen S; Guo L; Huang Y; Andresen BT
    PLoS One; 2019; 14(5):e0217038. PubMed ID: 31107911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic receptors: structure, function and regulation.
    De Blasi A
    Drugs Exp Clin Res; 1990; 16(3):107-12. PubMed ID: 1974837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained β-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activation.
    Nuamnaichati N; Sato VH; Moongkarndi P; Parichatikanond W; Mangmool S
    Life Sci; 2018 Jan; 193():257-269. PubMed ID: 29107793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: implications for anti-cancer drug targets.
    Al-Wadei HA; Ullah MF; Al-Wadei MH
    Pharmacol Res; 2012 Jul; 66(1):33-40. PubMed ID: 22487140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle.
    Igawa Y; Yamazaki Y; Takeda H; Hayakawa K; Akahane M; Ajisawa Y; Yoneyama T; Nishizawa O; Andersson KE
    Br J Pharmacol; 1999 Feb; 126(3):819-25. PubMed ID: 10188996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Blockers promote angiogenesis in the mouse aortic ring assay.
    Stati T; Musumeci M; Maccari S; Massimi A; Corritore E; Strimpakos G; Pelosi E; Catalano L; Marano G
    J Cardiovasc Pharmacol; 2014 Jul; 64(1):21-7. PubMed ID: 24621648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multifaceted role of beta-blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders.
    Cavalu S; Saber S; Amer AE; Hamad RS; Abdel-Reheim MA; Elmorsy EA; Abdelhamid AM
    FASEB J; 2024 Jul; 38(13):e23813. PubMed ID: 38976162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma.
    Shang ZJ; Liu K; Liang DF
    J Oral Pathol Med; 2009 Apr; 38(4):371-6. PubMed ID: 19141064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.